The promise of an exciting new drug that inhibits the mutant B-RAF protein in skin cancer is marred by the fact that most patients relapse within a year. Fresh data hint at how such resistance emerges. See Letters p.968 & p.973
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling
Oncogene Open Access 17 August 2015
-
Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?
BMC Medicine Open Access 12 August 2014
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Davies, H. et al. Nature 417, 949–954 (2002).
Bollag, G. et al. Nature 467, 596–599 (2010).
Flaherty, K. T. et al. N. Engl. J. Med. 363, 809–819 (2010).
Johannessen, C. M. et al. Nature 468, 968–972 (2010).
Nazarian, R. et al. Nature 468, 973–977 (2010).
Kantarjian, H. et al. N. Engl. J. Med. 362, 2260–2270 (2010).
Saglio, G. et al. N. Engl. J. Med. 362, 2251–2259 (2010).
Whittaker, S. et al. Sci. Transl. Med. 2, 35ra41 (2010).
Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M. & Rosen, N. Nature 464, 427–430 (2010).
Hatzivassiliou, G. et al. Nature 464, 431–435 (2010).
Heidorn, S. J. et al. Cell 140, 209–221 (2010).
Engelman, J. A. et al. Science 316, 1039–1043 (2007).
Montagut, C. et al. Cancer Res. 68, 4853–4861 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Solit, D., Sawyers, C. How melanomas bypass new therapy. Nature 468, 902–903 (2010). https://doi.org/10.1038/468902a
Published:
Issue Date:
DOI: https://doi.org/10.1038/468902a
This article is cited by
-
Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling
Oncogene (2016)
-
Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?
BMC Medicine (2014)
-
Drug repositioning for personalized medicine
Genome Medicine (2012)
-
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling
The EMBO Journal (2012)
-
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Nature Genetics (2012)